EXR
26
2
PVH
30
2
HSY
50
5
HRL
38
3
LOW
45
2
KIM
56
5
D
45
4
GIS
54
2
HOG
38
2
FITB
72
2
OMC
55
-7
AN
52
2
KMB
33
2
CVS
41
2
CSX
50
2
SO
53
5
MAS
63
3
HBAN
82
2
MU
79
3
SIG
52
2
EXR
26
2
PVH
30
2
HSY
50
5
HRL
38
3
LOW
45
2
KIM
56
5
D
45
4
GIS
54
2
HOG
38
2
FITB
72
2
OMC
55
-7
AN
52
2
KMB
33
2
CVS
41
2
CSX
50
2
SO
53
5
MAS
63
3
HBAN
82
2
MU
79
3
SIG
52
2
Financhill
Back

Axcelis Technologies, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
52

ACLS
Axcelis Technologies, Inc.

Last Price:
$82.69
Seasonality Move:
4.33%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
52
Axcelis Technologies, Inc. (ACLS) is a Buy

Is Axcelis Technologies, Inc. a Buy, Sell or Hold?

  • The current Axcelis Technologies, Inc. [ACLS] share price is $82.80. The Score for ACLS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • ACLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ACLS Stock Price Chart

What is Axcelis Technologies, Inc.'s stock price today?

  • The Axcelis Technologies, Inc. share price today is $82.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACLS is experiencing slight selling pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

ACLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 46.38 Sell
Chaikin Money Flow: -75158 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.18 - 88.42) Sell
Bollinger Bands (100): (78.58 - 90) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

ACLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.83 Sell
20-day SMA: 85.48 Sell
50-day SMA: 83.42 Sell
200-day SMA: 72.41 Buy
8-day EMA: 83.86 Sell
20-day EMA: 84.47 Sell
50-day EMA: 84.08 Sell
200-day EMA: 80.01 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Axcelis Technologies, Inc. Earnings Growth & ACLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.40 per share, and an increase next year of $0.11 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Axcelis Technologies, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):